Are predictors of coronary heart disease and lower-extremity arterial disease in type 1 diabetes the same? A prospective study

scientific article

Are predictors of coronary heart disease and lower-extremity arterial disease in type 1 diabetes the same? A prospective study is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/S0021-9150(99)00217-8
P698PubMed publication ID10580182

P50authorTrevor J. OrchardQ30223717
Lewis KullerQ88077314
Dorothy J BeckerQ100478508
P2093author name stringWolfson SK
Forrest KY
P2860cites workTobacco smoke is a source of toxic reactive glycation productsQ24623337
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) GroupQ27860882
Diabetes mellitus and macrovascular complications. An epidemiological perspectiveQ35373989
Visceral fat accumulation: the missing link between psychosocial factors and cardiovascular disease?Q37307932
Role of peptide growth factors in development of macrovascular complications of diabetesQ37770234
Dyslipoproteinemia and diabetes.Q37934887
Apo B-containing lipoprotein particles in poorly controlled insulin-dependent diabetesQ38563721
Advanced glycosylation end products in diabetic renal and vascular diseaseQ40383764
Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) Study, 1987-1993.Q40882910
Insulin resistance and obesity. The role of fat distribution patternQ41065203
The association of physical activity and diabetic complications in individuals with insulin-dependent diabetes mellitus: the Epidemiology of Diabetes Complications Study--VII.Q41852393
Physical activity as an index of heart attack risk in college alumniQ41870363
Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention TrialQ44459441
Factors associated with avoidance of severe complications after 25 yr of IDDM. Pittsburgh Epidemiology of Diabetes Complications Study I.Q44479744
Magnitude and determinants of coronary artery disease in juvenile-onset, insulin-dependent diabetes mellitusQ44553205
Choice of urine sample predictive of microalbuminuria in patients with insulin-dependent diabetes mellitusQ44894759
Prevalence and correlates of lower extremity arterial disease in elderly womenQ45158014
Veterans Affairs Cooperative Study on glycemic control and complications in type II diabetes (VA CSDM). Results of the feasibility trial. Veterans Affairs Cooperative Study in Type II DiabetesQ45335749
Mortality over a period of 10 years in patients with peripheral arterial diseaseQ46786119
Model of complications of NIDDM. I. Model construction and assumptions.Q50957725
Cardiovascular disease and its risk factors in IDDM in Europe. EURODIAB IDDM Complications Study Group.Q51010819
Coronary artery disease in IDDM. Gender differences in risk factors but not risk.Q51031928
The role of circulating glucose and triglyceride concentrations and their interactions with other "risk factors" as determinants of arterial disease in nine diabetic population samples from the WHO multinational study.Q51646479
Risk Factors Other Than Hyperglycemia in Diabetic Macrovascular DiseaseQ52302643
Assessment of peripheral vascular disease in diabetes. Report and recommendations of an international workshop sponsored by the American Heart Association and the American Diabetes Association 18-20 September 1992, New Orleans, Louisiana.Q53388767
Psychometric properties of the Beck Depression Inventory: Twenty-five years of evaluationQ59411806
Fibrinogen, viscosity and the 10-year incidence of ischaemic heart disease: The Caerphilly and Speedwell StudiesQ60687352
The hypertension detection and follow-up program: Hypertension detection and follow-up program cooperative groupQ67748287
Lipid and lipoprotein abnormalities in diabetic patients with peripheral vascular diseaseQ68011361
Atherosclerotic Vascular Disease and Its Risk Factors in Non-Insulin-Dependent Diabetic and Nondiabetic Subjects in FinlandQ68465607
Low incidence of fatal coronary heart disease in Pima Indians despite high prevalence of non-insulin-dependent diabetesQ68715449
Cardiovascular disease and arterial calcification in insulin-dependent diabetes mellitus: interrelations and risk factor profiles. Pittsburgh Epidemiology of Diabetes Complications Study-VQ70220095
A summary of criticisms of the findings and conclusions of the University Group Diabetes Program (UGDP)Q70442581
Atherosclerosis in diabetes mellitus. Correlations with serum lipid levels, adiposity, and serum insulin levelQ70505248
Hypertension: the major risk factor in juvenile-onset insulin-dependent diabeticsQ70973584
Incidence of complications in insulin-dependent diabetes mellitus: a survival analysisQ71024848
Risk factors for lower extremity arterial disease in non-insulin-dependent diabetic personsQ71214764
Subclinical Disease as an Independent Risk Factor for Cardiovascular DiseaseQ71974433
Vascular disease and serum lipids in diabetes mellitus. Observations over thirty years (1931-1961)Q76430984
P433issue1
P921main subjecttype-1 diabetesQ124407
P304page(s)159-169
P577publication date2000-01-01
P1433published inAtherosclerosisQ4813570
P1476titleAre predictors of coronary heart disease and lower-extremity arterial disease in type 1 diabetes the same? A prospective study
P478volume148

Reverse relations

cites work (P2860)
Q88801923Ambulatory blood pressure and arterial stiffness in individuals with type 1 diabetes
Q34970205Autoimmune-mediated vascular injury occurs prior to sustained hyperglycemia in a murine model of type I diabetes mellitus
Q46625403Cardiovascular disease in type 1 diabetes mellitus
Q36928042Changes in glycaemic control and risk of coronary artery disease in type 1 diabetes mellitus: findings from the Pittsburgh Epidemiology of Diabetes Complications Study (EDC).
Q35850628Coronary Atherosclerotic Plaque Detected by Computed Tomographic Angiography in Subjects with Diabetes Compared to Those without Diabetes
Q34959938Depression as a risk factor for cardiac mortality and morbidity: a review of potential mechanisms
Q77616770Diabetes mellitus and cardiovascular disease
Q37319716Diabetic dyslipidemia and cardiovascular risk
Q46613094Dicarbonyl intermediates in the maillard reaction
Q47367739Evaluation of factors related to glycaemic control among South Korean patients with type 2 diabetes.
Q49703070Exposure to High Glucose Concentration Decreases Cell Surface ABCA1 and HDL Biogenesis in Hepatocytes
Q36293473Fat food for a bad mood. Could we treat and prevent depression in Type 2 diabetes by means of omega-3 polyunsaturated fatty acids? A review of the evidence
Q49372861Hemoglobin A1c and Cardiovascular Disease Incidence in Type 1 Diabetes: An Application Of Joint Modeling Of Longitudinal And Time-To-Event Data In The Pittsburgh Epidemiology Of Diabetes Complications (EDC) Study
Q46613243High-dose thiamine therapy counters dyslipidemia and advanced glycation of plasma protein in streptozotocin-induced diabetic rats
Q34327231Hyperglycemia and cardiovascular disease
Q49312017Hypertension in Non-Type 2 Diabetes in Isfahan, Iran: Incidence and Risk Factors.
Q46295619Hypertension is the metabolic syndrome component most strongly associated with microvascular complications and coronary artery calcification in Type 1 diabetes
Q34459819Increase in GLUT1 in Smooth Muscle Alters Vascular Contractility and Increases Inflammation in Response to Vascular Injury
Q34448739Insulin resistance, defective insulin-mediated fatty acid suppression, and coronary artery calcification in subjects with and without type 1 diabetes: The CACTI study
Q35708823Light therapy for better mood and insulin sensitivity in patients with major depression and type 2 diabetes: a randomised, double-blind, parallel-arm trial
Q44438940Lipoprotein subclass measurements by nuclear magnetic resonance spectroscopy improve the prediction of coronary artery disease in Type 1 Diabetes. A prospective report from the Pittsburgh Epidemiology of Diabetes Complications Study
Q35006841Lipoprotein-associated phospholipase A₂ activity predicts progression of subclinical coronary atherosclerosis
Q37857087Macrovascular angiopathy in children and adolescents with type 1 diabetes.
Q35548457Myocardial structure, function, and scar in patients with type 1 diabetes mellitus
Q34804227Neurovascular disease, antioxidants and glycation in diabetes
Q36675872Predicting the development of macrovascular disease in people with type 1 diabetes: A 9-year follow-up study
Q34384850Pulse wave analysis and prevalent cardiovascular disease in type 1 diabetes
Q34457354Quality-of-life measures as predictors of mortality and morbidity.
Q90152592Recent trends over time in vascular disease in type 1 diabetes: insights from the Pittsburgh Epidemiology of Diabetes Complications study
Q37731747Risk stratification for 25-year cardiovascular disease incidence in type 1 diabetes: Tree-structured survival analysis of the Pittsburgh Epidemiology of Diabetes Complications study
Q36416215Role of diabetes in atherosclerotic pathogenesis. What have we learned from animal models?
Q36086134Significance of Epicardial and Intrathoracic Adipose Tissue Volume among Type 1 Diabetes Patients in the DCCT/EDIC: A Pilot Study
Q45181782Six-year incidence of lower extremity arterial disease and associated risk factors in Type 1 diabetic African-Americans
Q43813831The associations among thoracic aortic atherosclerosis, coronary atherosclerosis and the function of high density lipoprotein
Q37239766The effect of intensive glycemic treatment on coronary artery calcification in type 1 diabetic participants of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study
Q34959974Treatment of depression in diabetes: impact on mood and medical outcome
Q40627664Trends in hypertension management in Type I diabetes across Europe, 1989/1990 - 1997/1999.
Q34219439Type 1 diabetes mellitus and cardiovascular disease: a scientific statement from the American Heart Association and American Diabetes Association
Q37172723Type 1 diabetes, hyperglycaemia, and the heart
Q36023075Vascular risk: diabetes
Q38012702Why critical limb ischemia criteria are not applicable to diabetic foot and what the consequences are.

Search more.